Literature DB >> 24276521

Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem.

Joachim Havla1, Reinhard Hohlfeld, Tania Kümpfel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24276521     DOI： 10.1007/s00415-013-7191-9

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

Authors:  J Kuhle; R Gosert; R Bühler; T Derfuss; R Sutter; O Yaldizli; E-W Radue; C Ryschkewitsch; E O Major; L Kappos; S Frank; H H Hirsch
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

2.  Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.

Authors:  Carla Tortorella; Vita Direnzo; Mariangela D'Onghia; Maria Trojano
Journal:  Neurology       Date:  2013-10-15       Impact factor: 9.910

3.  Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.

Authors:  A Vennegoor; M P Wattjes; E T L van Munster; R L Kriekaart; B W van Oosten; F Barkhof; J Killestein; C H Polman
Journal:  Neurology       Date:  2011-02-08       Impact factor: 9.910

4.  Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Tarek A Yousry; Daniel Pelletier; Diego Cadavid; Achim Gass; Nancy D Richert; Ernst-Wilhelm Radue; Massimo Filippi
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

5.  Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group".

Authors:  J Havla; A Berthele; T Kümpfel; M Krumbholz; A Jochim; H Kronsbein; C Ryschkewitsch; P Jensen; K Lippmann; B Hemmer; E Major; R Hohlfeld
Journal:  Mult Scler       Date:  2012-11-01       Impact factor: 6.312
  5 in total
  6 in total

1.  Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?

Authors:  Mike P Wattjes; Anke Vennegoor; Jop Mostert; Bob W van Oosten; Frederik Barkhof; Joep Killestein
Journal:  J Neurol       Date:  2014-04-06       Impact factor: 4.849

2.  Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.

Authors:  Martijn T Wijburg; Iris Kleerekooper; Birgit I Lissenberg-Witte; Marlieke de Vos; Clemens Warnke; Bernard M J Uitdehaag; Frederik Barkhof; Joep Killestein; Mike P Wattjes
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

3.  Brainstem progressive multifocal leukoencephalopathy.

Authors:  Gautier Breville; Igor J Koralnik; Patrice H Lalive
Journal:  Eur J Neurol       Date:  2020-12-01       Impact factor: 6.089

Review 4.  Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.

Authors:  Martijn T Wijburg; Bob W van Oosten; Jean-Luc Murk; Ouafae Karimi; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2014-10-09       Impact factor: 6.682

5.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 6.  Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

Authors:  Irene Cortese; Daniel S Reich; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2020-11-20       Impact factor: 42.937
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.